Kim DW, Chul Cho B, Pachipala K, Kim SW, et al. Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study. Lung Cancer 2024;190:107530.
PMID: 38471416